Logo Rosalind & Morris Goodman Cancer Institute

Professor Morag Park

This year has been another great success for our principal investigators, trainees and staff, filled with major accomplishments and important scientific advances.

I am delighted to present the 2022-23 Annual Report of the Rosalind and Morris Goodman Cancer Institute (GCI), following a year in which our institute has continued to enjoy remarkable success. Driven by the talent and dedication of our investigators, trainees, and staff, we are pushing the boundaries of cancer research. Among the most exciting recent developments has been the rapid progress of RNA technology, which promises to provide cancer patients with a wealth of safer and more effective treatments. Importantly, the breakthroughs that have led us to this point were built on fundamental scientific enquiry, with GCI scientists among the leaders in the field from its inception to the present day.

This report presents a snapshot of the GCI’s many achievements and activities throughout the 2022-23 fiscal year, highlighting our major scientific discoveries, publications and recognition, and growing networks of partnerships throughout Quebec, across Canada and around the world. It shows our progress as an institute, highlighted by our achievement of FRQS Research Centre status, while presenting our vision of a future that is driven by cutting-edge research and enabled by training the next generation of cancer research leaders.

Our discoveries are made possible by the generosity of our donors and supporters at every step of the way. With your sustained support, the GCI will continue to provide the knowledge needed to bring hope to patients, their caregivers and families.

Professor Morag Park

Director, Rosalind and Morris Goodman Cancer Institute
Diane and Sal Guerrera Chair in Cancer Genetics
Distinguished James McGill Professor, Depts. of Oncology,
Biochemistry and Medicine, McGill University
thumbnail

Annual Report  2022-2023

The 2022-2023 GCI annual report embraces the theme of momentum and spotlights our newly attained status as a distinguished FRQS Research Centre, emphasizing the GCI's significance in the cancer research landscape, both within Quebec and beyond. At this strategically opportune juncture, we are harnessing our momentum as a FRQS-funded Institute, moving rapidly towards the promise of precision cancer medicine. Our researchers have made remarkable strides, from cancer biomarkers to RNA-based therapies, advancing cancer diagnosis, treatment, and outcomes. The report also commends the dedication of our principal investigators, trainees, and staff who continually push boundaries, driving essential scientific advancements.

Download

 

thumbnail

Annual Report  
2021-2022

Download

thumbnail

Annual Report  
2020-2021

Download

thumbnail

Annual Report  
2019-2020

Download

thumbnail

Annual Report  
2016-2017

Download